Brenntag SE, the German chemicals distribution group, saw its shares move lower a day after releasing preliminary results for the second quarter. The company reported preliminary operating EBITDA of around 450 million for Q2 and followed with an upward revision to its full-year 2026 guidance.
The preliminary Q2 operating EBITDA figure beat the analyst consensus mean of 366.9 million, as compiled by Vara Research from eight analysts as of June 22. Jefferies calculated the reported number represented a 35% year-over-year increase and noted it exceeded the brokerages own consensus estimate of 353 million by 27%.
Brenntag attributed the stronger performance to "robust current demand and improved margins, particularly in the context of market disruptions resulting from the crisis in the Middle East." Based on the second-quarter results, management lifted its full-year 2026 operating EBITDA guidance to a range of 1.25 billion to 1.40 billion, up from a prior range of 1.15 billion to 1.35 billion.
Jefferies observed the raised guidance is "in line with consensus 1,332mn at the midpoint." Nonetheless, Brenntag underscored a cautious stance, noting the company "remains cautious given the continued uncertainty and the risk of demand weakness in the second half of the year."
On the question of seasonal earnings distribution, Jefferies calculated the new guidance implies a H2 weighting of 43% at the midpoint, which it said is 440 basis points below the five-year average skew of 51/49. The brokerage kept a "hold" rating on the stock and a price target of 56, representing around 4% upside from the most recently reported closing price of 53.90.
Investors reacted to the mix of a strong quarterly print and an upbeat guidance range tempered by managements caution, leading to downward pressure on the shares in subsequent trading. The results and commentary highlight the company's near-term earnings strength alongside continued sensitivity to demand patterns in the latter half of the year.
Key context and market implications
- The company outperformed consensus on operating EBITDA in Q2, driven by demand and wider margins amid regional market disruptions.
- Full-year 2026 operating EBITDA guidance was raised to 1.25 billion- 1.40 billion, aligning with consensus at the midpoint according to Jefferies.
- Management emphasized persistent uncertainty and potential demand weakness for H2, which influenced investor sentiment despite the stronger results.